{{medical}}
{{Infobox drug
| IUPAC_name        = ''N'',''N''-Dimethylimidodicarbonimidic diamide
| image             = Metformin.svg
| alt               = 
| image2            = Metformin-from-xtal-3D-balls.png
| alt2              = 
| caption           =
<!--Clinical data -->
| pronounce   = {{IPAc-en|m|ɛ|t|ˈ|f|ɔr|m|ɨ|n}}, {{respell|met|FAWR|min}}
| tradename         = Glucophage, other
| Drugs.com         = {{drugs.com|monograph|metformin-hydrochloride}}
| MedlinePlus       = a696005
| licence_EU        = <!-- EMA requires brand name -->
| licence_US        = metformin
| DailyMedID        = <!-- preference to licence_US -->
| pregnancy_AU      = C
| pregnancy_US      = B
| pregnancy_category= 
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| legal_status      = 
| dependency_liability = 
| routes_of_administration = 口服

<!--Pharmacokinetic data -->
| bioavailability   = 50–60%<ref name = D95>{{cite journal |vauthors=Dunn CJ, Peters DH | title = Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus | journal = Drugs | volume = 49 | issue = 5 | pages = 721–49 |date=May 1995  | pmid = 7601013 | doi = 10.2165/00003495-199549050-00007 }}</ref><ref name=D03>{{cite journal |vauthors=Hundal RS, Inzucchi SE | title = Metformin: new understandings, new uses | journal = Drugs | volume = 63 | issue = 18 | pages = 1879–94 | year = 2003 | pmid = 12930161 | doi = 10.2165/00003495-200363180-00001 }}</ref>
| protein_bound     = 很小<ref name = D95/>
| metabolism        = 不经过肝脏<ref name = D95/>
| elimination_half-life = 4-8.7小时<ref name = D95/>
| excretion         = 尿液（90%）<ref name = D95/>

<!--Identifiers -->
| index0 = 
| index2 = hydrochloride
| CAS_number        = 657-24-9
| CAS_number_Ref = {{cascite|correct}}
| CAS_supplemental  = 
| IUPHAR_ligand = 4779
| synonyms          = 
| PubChem = 4091
| ChemSpiderID = 3949
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| UNII = 9100L32L2N
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII2 = 786Z46389E
| DrugBank = DB00331
| KEGG = D04966
| KEGG_Ref = {{keggcite|correct|kegg}}
| ChEBI = 6801
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1431
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ATC_prefix = A10
| ATC_suffix = BA02

<!--Chemical data -->
| chemical_formula  =
| C=4 | H=11 | N=5
| molecular_weight  = 129.16364 g/mol
| smiles            = CN(C)C(=N)NC(=N)N
| StdInChI          = 1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)
| StdInChI_comment  = 
| StdInChIKey       = XZWYZXLIPXDOLR-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| density           = 
| melting_point     = 
| boiling_point     = 
| solubility        = 
| specific_rotation = 
| sec_combustion    = 
}}
<!-- Definition and medical uses -->
'''二甲双{{ruby-py|胍|-{zh-cn:guā;zh-tw:ㄍㄨㄚˉ;zh-hk:gwaa<sup>1</sup>}-}}'''（{{lang-en|Metformin}}）{{notetag|{{標音|字=胍|注音=ㄍㄨㄚ |拼音=guā|同音字=瓜}}}}，常見商品名'''格华止'''、'''庫魯化'''（{{lang|en|Glucophage}}），為治疗[[2型糖尿病|2型糖尿病]]的[[療法|一线药物]]<ref name=AHFS2016/><ref name=Ann2016>{{cite journal|last1=Maruthur|first1=NM|last2=Tseng|first2=E|last3=Hutfless|first3=S|last4=Wilson|first4=LM|last5=Suarez-Cuervo|first5=C|last6=Berger|first6=Z|last7=Chu|first7=Y|last8=Iyoha|first8=E|last9=Segal|first9=JB|last10=Bolen|first10=S|title=Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.|journal=Annals of Internal Medicine|date=19 April 2016|pmid=27088241|doi=10.7326/M15-2650}}</ref>，特别是针对[[超重|超重]]的患者<ref>{{cite book|title=Clinical Obesity.|date=2008|publisher=John Wiley & Sons|location=Oxford|isbn=9781405143660|page=262|edition=2nd|url=https://books.google.it/books?id=qGVnItPoPCYC&pg=PA262|access-date=2016-09-07|archive-date=2020-09-14|archive-url=https://web.archive.org/web/20200914214852/https://books.google.it/books?id=qGVnItPoPCYC&pg=PA262|dead-url=no}}</ref>。本品也可用於治療[[多囊卵巢綜合症|多囊卵巢綜合症]]<ref name=AHFS2016/>，少數研究顯示也能用於預防糖尿病患者包含如[[心血管疾病|心血管疾病]]及[[癌症|癌症]]的併發症<ref>{{cite journal|last=Malek|first=M|author2=Aghili, R|author3=Emami, Z|author4=Khamseh, ME|title=Risk of Cancer in Diabetes: The Effect of Metformin.|journal=ISRN Endocrinology|date=2013|volume=2013|pages=636927|doi=10.1155/2013/636927|pmid=24224094|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800579/pdf/ISRN.ENDOCRINOLOGY2013-636927.pdf|format=PDF|pmc=3800579|access-date=2016-09-07|archive-date=2017-09-08|archive-url=https://web.archive.org/web/20170908185309/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800579/pdf/ISRN.ENDOCRINOLOGY2013-636927.pdf|dead-url=no}}</ref><ref name=Pres2014>{{cite journal|title=Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.|journal=Prescrire international|date=November 2014|volume=23|issue=154|pages=269–72|pmid=25954799}}</ref>。本品屬於口服藥物<ref name=AHFS2016/>，且用藥不會造成體重增加<ref name=Pres2014/>。

<!-- Side effects and mechanism -->
二甲雙[[胍|胍]]在人體通常沒有顯著副作用<ref>{{cite journal|last1=Triggle|first1=CR|last2=Ding|first2=H|title=Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium.|journal=Acta physiologica (Oxford, England)|date=17 December 2015|pmid=26680745|doi=10.1111/apha.12644}}</ref>。常見副作用包含[[腹瀉|腹瀉]]、[[惡心|惡心]]，以及腹痛<ref name=AHFS2016/>，造成[[低血糖|低血糖]]的機會不大<ref name=AHFS2016/>。但值得關注的是，不當用藥可能會導致{{tsl|en|Lactic acidosis|乳酸中毒}}，嚴重者甚至會死亡<ref name="pmid21617112">{{cite journal |vauthors=Lipska KJ, Bailey CJ, Inzucchi SE | title = Use of metformin in the setting of mild-to-moderate renal insufficiency |url=https://archive.org/details/sim_diabetes-care_2011-06_34_6/page/1431 | journal = Diabetes Care | volume = 34 | issue = 6 | pages = 1431–7 |date=June 2011 | pmid = 21617112 | pmc = 3114336 | doi = 10.2337/dc10-2361 }}</ref>。肝病、[[腎功能衰竭|腎功能衰竭]]者不宜服用本品<ref name=AHFS2016/>，妊娠期間用藥目前沒有已知影響，但[[妊娠糖尿病|妊娠糖尿病]]一般建議以胰島素進行治療<ref name=AHFS2016/><ref>{{cite journal|last1=Lautatzis|first1=ME|last2=Goulis|first2=DG|last3=Vrontakis|first3=M|title=Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.|journal=Metabolism: clinical and experimental|date=November 2013|volume=62|issue=11|pages=1522–34|pmid=23886298|doi=10.1016/j.metabol.2013.06.006}}</ref>。本品屬於[[雙胍類|雙胍類]]藥物<ref name=AHFS2016>{{cite web|title=Metformin Hydrochloride|url=http://www.drugs.com/monograph/metformin-hydrochloride.html|publisher=The American Society of Health-System Pharmacists|accessdate=Jan 2016|archive-date=2016-12-24|archive-url=https://web.archive.org/web/20161224162245/https://www.drugs.com/monograph/metformin-hydrochloride.html|dead-url=no}}</ref>，藉由降低[[肝臟|肝臟]][[糖异生|糖質新生]]及提升胰島素敏感度來達到治療的效果<ref name=AHFS2016/>。

<!-- History, society, and culture -->
二甲双胍最早於1922年發現<ref name=Fis2010>{{cite book|last1=Fischer|first1=Janos|title=Analogue-based Drug Discovery II|date=2010|publisher=John Wiley & Sons|isbn=9783527632121|pages=47–49|url=https://books.google.co.jp/books?id=h2Kd8ci4Ln8C&pg=PA47|access-date=2016-09-07|archive-date=2020-12-09|archive-url=https://web.archive.org/web/20201209104527/https://books.google.co.jp/books?id=h2Kd8ci4Ln8C&pg=PA47|dead-url=no}}</ref>，但直到1950年代，法國內科醫師讓·斯特恩（Jean Sterne）開啟了二甲双胍人类应用的临床研究<ref name=Fis2010/>。1957年，本品開始在法國用於藥用，並於1995年開始於美國使用<ref name=AHFS2016/><ref>{{cite book|last1=McKee|first1=Mitchell Bebel Stargrove, Jonathan Treasure, Dwight L.|title=Herb, nutrient, and drug interactions : clinical implications and therapeutic strategies|date=2008|publisher=Mosby/Elsevier|location=St. Louis, Mo.|isbn=9780323029643|page=217|url=https://books.google.co.jp/books?id=49kLK--eumEC&pg=PA217|access-date=2016-09-07|archive-date=2020-09-14|archive-url=https://web.archive.org/web/20200914230359/https://books.google.co.jp/books?id=49kLK--eumEC&pg=PA217|dead-url=no}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref>{{cite web|title=WHO Model List of EssentialMedicines|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=22 April 2014|date=October 2013|archive-date=2016-04-11|archive-url=https://web.archive.org/web/20160411133939/http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|dead-url=no}}</ref>。目前相信口服給藥是最有效的給藥途徑<ref name=Fis2010/>，本品屬於[[通用名藥物|通用名藥物]]<ref name=AHFS2016/>。2014年本品於[[已開發國家|已開發國家]]的批發價為0.21至5.55美元之間<ref>{{cite web|title=Metformin|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=ME500T&s_year=2014&year=2014&str=500%20mg&desc=Metformin%20HCl&pack=new&frm=TAB-CAP&rte=PO&class_code2=18%2E5%2E&supplement=&class_name=%2818%2E5%2E%29Insulins%20and%20medicines%20used%20for%20diabetes%3Cbr%3E|accessdate=11 January 2016}}{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>。在美國，一個月療程的藥物花費約於 5 至 25 美元之間<ref name=AHFS2016/>。

[[File:Metformin_500mg_Tablets.jpg|thumb]]|alt=|424x424px]]

==药理==
二甲双胍的分子药理机制目前尚不完全清楚。已知其至少作用于[[肝脏|肝脏]]，减少[[糖异生|糖异生]]（即葡萄糖的生产）与减轻[[胰岛素|胰岛素]]抵抗<ref>{{cite web | url = http://www.onlineclinic.co.uk/metformin.html | publisher = OnlineClinic | title = How does this medication work? | accessdate = 2015-01-30 | archive-date = 2016-07-22 | archive-url = https://web.archive.org/web/20160722062937/http://www.onlineclinic.co.uk/metformin.html | dead-url = no }}</ref>。有研究表明二甲双胍可激活{{tsl|en|AMP-activated protein kinase|单磷酸腺苷活化的蛋白激酶}}（AMP-activated protein kinase，AMPK），是二甲双胍抑制肝脏糖异生、在胰岛素信号传导通路中提高胰岛素的敏感性不可缺少的机制之一<ref name="Zhou">{{cite journal | vauthors = Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE | display-authors = 6 | title = Role of AMP-activated protein kinase in mechanism of metformin action | journal = The Journal of Clinical Investigation | volume = 108 | issue = 8 | pages = 1167–74 | date = October 2001 |language=en | pmid = 11602624 | pmc = 209533 | doi = 10.1172/JCI13505 }}</ref>。AMPK作为[[蛋白激酶|蛋白激酶]]不仅在胰岛素信号传导通路中，在全身能量平衡以及葡萄糖和脂肪的代谢中也起着重要作用<ref>{{cite journal | vauthors = Towler MC, Hardie DG | title = AMP-activated protein kinase in metabolic control and insulin signaling | journal = Circulation Research | volume = 100 | issue = 3 | pages = 328–41 | date = February 2007 |language=en | pmid = 17307971 | doi = 10.1161/01.RES.0000256090.42690.05 }}</ref>。动物实验和临床研究均表明二甲双胍可诱导糖尿病的粪便微生物菌群构成发生重大变化，不仅可能有助于[[胰高血糖素样肽-1|胰高血糖素样肽-1]]（GLP-1）的分泌及作用，还证实可改善胰岛素的敏感性，也是其抗2型糖尿病作用的重要机制之一<ref name ="Burcelin">{{cite journal | vauthors = Burcelin R | title = The antidiabetic gutsy role of metformin uncovered? | journal = Gut | volume = 63 | issue = 5 | pages = 706–7 | date = May 2014 |language=en | pmid = 23840042 | doi = 10.1136/gutjnl-2013-305370 }}</ref><ref>{{Cite journal |title=Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug |url=https://www.nature.com/articles/nm.4345 |last=Wu |first=Hao |last2=Esteve |first2=Eduardo |date=2017-07 |journal=Nature Medicine |issue=7 |doi=10.1038/nm.4345 |volume=23 |pages=850–858 |language=en |issn=1546-170X |last3=Tremaroli |first3=Valentina |last4=Khan |first4=Muhammad Tanweer |last5=Caesar |first5=Robert |last6=Mannerås-Holm |first6=Louise |last7=等 |access-date=2021-04-11 |archive-date=2017-12-11 |archive-url=https://web.archive.org/web/20171211103001/https://www.nature.com/articles/nm.4345 }}</ref>。

==优势==
* 不会增加体重
* 与其他药品相比不易造成低血糖
* 减少三酸甘油酯
* 对低密度脂蛋白有很好的效果
* 对血压无影响
* 价格低廉

==缺点==
* 患中到重度肾脏疾病或心脏病者忌用，因为可能由于[[酗酒|酗酒]]导致[[乳酸|乳酸]]性[[酸中毒|酸中毒]]。
* 肠胃道症狀，包括噁心、腹泻、腹痛
* [[维生素B12|维生素B12]]缺乏
* 金属味觉

==抗衰老研究==
一些資料顯示，服用二甲双胍的糖尿病患者，其[[存活率|存活率]]甚至超過其他条件类似但未患糖尿病的人群<ref>{{Cite journal|title=Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls|url=https://pubmed.ncbi.nlm.nih.gov/25041462/|last=Bannister|first=C. A.|last2=Holden|first2=S. E.|date=2014-11|journal=Diabetes, Obesity & Metabolism|issue=11|doi=10.1111/dom.12354|volume=16|pages=1165–1173|issn=1463-1326|pmid=25041462|last3=Jenkins-Jones|first3=S.|last4=Morgan|first4=C. Ll|last5=Halcox|first5=J. P.|last6=Schernthaner|first6=G.|last7=Mukherjee|first7=J.|last8=Currie|first8=C. J.|access-date=2021-08-12|archive-date=2022-04-05|archive-url=https://web.archive.org/web/20220405005708/https://pubmed.ncbi.nlm.nih.gov/25041462/}}</ref>，而對二甲双胍在人類身上是否有抗[[衰老|衰老]]效果的臨床實驗預計於2016年冬在美國開始進行。<ref>{{Cite news |url=http://www.chinanews.com/gj/2015/12-02/7652205.shtml |title=世界首例抗衰老药将临床试验 或让人活到120岁 |publisher=中新網 |date=2015-12-02 |accessdate=2015-12-02 |archive-date=2020-09-16 |archive-url=https://web.archive.org/web/20200916131723/http://www.chinanews.com/gj/2015/12-02/7652205.shtml |dead-url=no }}</ref>

== 註解 ==
{{NoteFoot}}

== 参考文献 ==
{{Reflist|30em}}

==延伸閲讀==
{{refbegin|2}}
* {{cite journal |vauthors=Markowicz-Piasecka M, Huttunen KM, Mateusiak L, Mikiciuk-Olasik E, Sikora J |display-authors=3 |title=Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics |journal=Curr. Pharm. Des. |volume=23 |issue=17 |pages=2532–2550 |date=2017 |pmid=27908266 |doi=10.2174/1381612822666161201152941 |url=}}
* {{cite journal |vauthors=McCreight LJ, Bailey CJ, Pearson ER |title=Metformin and the gastrointestinal tract |journal=Diabetologia |volume=59 |issue=3 |pages=426–35 |date=March 2016 |pmid=26780750 |pmc=4742508 |doi=10.1007/s00125-015-3844-9 |url=}}
* {{cite journal |vauthors=Moin T, Schmittdiel JA, Flory JH, Yeh J, Karter AJ, Kruge LE, Schillinger D, Mangione CM, Herman WH, Walker EA |display-authors=3 |title=Review of Metformin Use for Type 2 Diabetes Prevention |journal=Am J Prev Med |volume=55 |issue=4 |pages=565–574 |date=October 2018 |pmid=30126667 |pmc=6613947 |doi=10.1016/j.amepre.2018.04.038 |url=}}
* {{cite journal |vauthors=Rena G, Hardie DG, Pearson ER |title=The mechanisms of action of metformin |journal=Diabetologia |volume=60 |issue=9 |pages=1577–1585 |date=September 2017 |pmid=28776086 |pmc=5552828 |doi=10.1007/s00125-017-4342-z |url=}}
* {{cite journal |vauthors=Sanchez-Rangel E, Inzucchi SE |title=Metformin: clinical use in type 2 diabetes |journal=Diabetologia |volume=60 |issue=9 |pages=1586–1593 |date=September 2017 |pmid=28770321 |doi=10.1007/s00125-017-4336-x |url=}}
* {{cite journal |vauthors=Zhou J, Massey S, Story D, Li L |display-authors=3 |title=Metformin: An Old Drug with New Applications |journal=Int J Mol Sci |volume=19 |issue=10 |pages= |date=September 2018 |pmid=30241400 |pmc=6213209 |doi=10.3390/ijms19102863 |url=}}
* {{cite journal |vauthors=Zhou T, Xu X, Du M, Zhao T, Wang J |display-authors=3 |title=A preclinical overview of metformin for the treatment of type 2 diabetes |journal=Biomed. Pharmacother. |volume=106 |issue= |pages=1227–1235 |date=October 2018 |pmid=30119191 |doi=10.1016/j.biopha.2018.07.085 |url=}}
{{refend}}

==外部連結==
{{Commons category|Metformin}}
{{Portal|藥理學|醫學}}
* {{cite web | url = https://druginfo.nlm.nih.gov/drugportal/name/metformin | publisher = U.S. National Library of Medicine | work = Drug Information Portal | title = Metformin | accessdate = 2020-02-16 | archive-date = 2020-11-02 | archive-url = https://web.archive.org/web/20201102145731/https://druginfo.nlm.nih.gov/drugportal/name/Metformin | dead-url = no }}
{{-}}
{{Oral hypoglycemics and insulin analogs|state=collapsed}}

[[Category:胍|Category:胍]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:糖尿病药物|Category:糖尿病药物]]